Funding rounds/Aurealis Pharma

Aurealis Pharma

Series B

Kuopio, FinlandFounded 2010Dec 2018

Amount raised

€6.7M

€6,708,000

Native amount

7,800,000 CHF

Stage

Series B

series b

Investors

Provenance & confidence

High confidence

Amount

7,800,000 CHF

ECB-at-date → €6.9M · rate 1.1269 on 2018-12-31

stored → €6.7M

High confidence

Source

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Date

Dec 2018

Round type

series b

Amount (EUR)

€6.7M

same company

This is the company's only recorded round.